Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer?
Alhamarneh, Osama; Amarnath, Shoba M. P.; Stafford, Nicholas D.; Greenman, John
Shoba M. P. Amarnath
Nicholas D. Stafford
Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology
Advances in the treatment modalities for head and neck squamous cell carcinoma (HNSCC) over the last 20 years involving surgery, radiotherapy, chemotherapy, and immunotherapy are not fully reflected in increases in the 5-year survival rates, mainly due to locoregional recurrences and to a lesser extent, distant metastasis. This can, in part, be attributed to the fact that HNSCC induces severe depression of a patient's immune system. Recent advances in understanding the complex host-tumor interactions have led to the identification of a distinct suppressor cell population known as regulatory T cells that play a crucial role in maintaining T-cell tolerance to self-antigens. Here, we present a critical review of our understanding of the involvement of regulatory T cells in controlling the T-cell immune response in tumor occurrence and progression in HNSCC with an emphasis on current and future immunotherapeutic approaches involving regulatory T cells.
Alhamarneh, O., Amarnath, S. M. P., Stafford, N. D., & Greenman, J. (2008). Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer?. Head & neck, 30(2), 251-261. https://doi.org/10.1002/hed.20739
|Journal Article Type||Review|
|Acceptance Date||Feb 28, 2008|
|Online Publication Date||Jan 9, 2008|
|Journal||HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK|
|Peer Reviewed||Peer Reviewed|
This file is under embargo due to copyright reasons.
You might also like
Arginine methylation: the promise of a ‘silver bullet’ for brain tumours?